Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Rock

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Current Opinion in Immunology|May 2, 2023
Tumor immune evasion through loss of MHC class-I antigen presentationGulce Sari, Kenneth L Rock
The Journal of Biological Chemistry|May 24, 2020
How a tailor achieves the perfect fitJeff D Colbert, Kenneth L Rock
Trends in Immunology|September 12, 2016
Present Yourself! By MHC Class I and MHC Class II MoleculesKenneth L Rock, Eric Reits, Jacques Neefjes
European Journal of Pharmacology|December 3, 2014
The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lungHiroshi Kataoka, Ke Yang, Kenneth L Rock
Nature Reviews. Rheumatology|September 5, 2012
Uric acid as a danger signal in gout and its comorbiditiesKenneth L Rock, Hiroshi Kataoka, Jiann-Jyh Lai
Seminars in Immunology|February 22, 2023
Pathways of MHC I cross-presentation of exogenous antigensFreidrich M Cruz, Amanda Chan, Kenneth L Rock
Immunological Reviews|September 3, 2011
Innate and adaptive immune responses to cell deathKenneth L Rock, Jiann-Jyh Lai, Hajime Kono
Frontiers in Immunology|March 26, 2021
Cancer Immune Evasion Through Loss of MHC Class I Antigen PresentationKarthik Dhatchinamoorthy, Jeff D Colbert, Kenneth L Rock
Nature|October 2, 2003
Molecular identification of a danger signal that alerts the immune system to dying cellsYan Shi, James E Evans, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes modelYan Shi, Shelly A Galusha, Kenneth L Rock
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Current Opinion in Immunology|May 2, 2023
Tumor immune evasion through loss of MHC class-I antigen presentationGulce Sari, Kenneth L Rock
The Journal of Biological Chemistry|May 24, 2020
How a tailor achieves the perfect fitJeff D Colbert, Kenneth L Rock
Trends in Immunology|September 12, 2016
Present Yourself! By MHC Class I and MHC Class II MoleculesKenneth L Rock, Eric Reits, Jacques Neefjes
European Journal of Pharmacology|December 3, 2014
The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lungHiroshi Kataoka, Ke Yang, Kenneth L Rock
Nature Reviews. Rheumatology|September 5, 2012
Uric acid as a danger signal in gout and its comorbiditiesKenneth L Rock, Hiroshi Kataoka, Jiann-Jyh Lai
Seminars in Immunology|February 22, 2023
Pathways of MHC I cross-presentation of exogenous antigensFreidrich M Cruz, Amanda Chan, Kenneth L Rock
Immunological Reviews|September 3, 2011
Innate and adaptive immune responses to cell deathKenneth L Rock, Jiann-Jyh Lai, Hajime Kono
Frontiers in Immunology|March 26, 2021
Cancer Immune Evasion Through Loss of MHC Class I Antigen PresentationKarthik Dhatchinamoorthy, Jeff D Colbert, Kenneth L Rock
Nature|October 2, 2003
Molecular identification of a danger signal that alerts the immune system to dying cellsYan Shi, James E Evans, Kenneth L Rock
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Cutting edge: elimination of an endogenous adjuvant reduces the activation of CD8 T lymphocytes to transplanted cells and in an autoimmune diabetes modelYan Shi, Shelly A Galusha, Kenneth L Rock
Pageof 9